INMUNE BIO INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INMUNE BIO INC. stock issued during period, shares, new issues for fiscal 2022 was 4.84M shares, a 18.17% increase from fiscal 2021.
- INMUNE BIO INC. stock issued during period, shares, new issues for fiscal 2021 was 4.10M shares.
- INMUNE BIO INC. stock issued during period, shares, new issues for fiscal 2018 was 400.00K shares, a 71.29% decline from fiscal 2017.
- INMUNE BIO INC. stock issued during period, shares, new issues for fiscal 2017 was 1.39M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2022-12-31 | 4.84M shares 10-K · filed 2023-03-02 | |
| 2021-12-31 | 4.10M shares 10-K · filed 2023-03-02 | |
| 2018-12-31 | 400.00K shares 10-K · filed 2019-03-29 | |
| 2017-12-31 | 1.39M shares 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |